464 related articles for article (PubMed ID: 18171218)
1. Higher mRNA levels of chemokines and cytokines associated with macrophage activation in erythema migrans skin lesions in patients from the United States than in patients from Austria with Lyme borreliosis.
Jones KL; Muellegger RR; Means TK; Lee M; Glickstein LJ; Damle N; Sikand VK; Luster AD; Steere AC
Clin Infect Dis; 2008 Jan; 46(1):85-92. PubMed ID: 18171218
[TBL] [Abstract][Full Text] [Related]
2. Comparison of erythema migrans caused by Borrelia afzelii and Borrelia garinii.
Logar M; Ruzić-Sabljić E; Maraspin V; Lotric-Furlan S; Cimperman J; Jurca T; Strle F
Infection; 2004 Feb; 32(1):15-9. PubMed ID: 15007737
[TBL] [Abstract][Full Text] [Related]
3. High levels of inflammatory chemokines and cytokines in joint fluid and synovial tissue throughout the course of antibiotic-refractory lyme arthritis.
Shin JJ; Glickstein LJ; Steere AC
Arthritis Rheum; 2007 Apr; 56(4):1325-35. PubMed ID: 17393419
[TBL] [Abstract][Full Text] [Related]
4. Concentrations of macrophage inflammatory proteins MIP-1alpha and MIP-1beta and interleukin 8 (il-8) in lyme borreliosis.
Grygorczuk S; Pancewicz S; Zajkowska J; Kondrusik M; Rwierzbińska R; Hermanowska-Szpakowicz T
Infection; 2004 Dec; 32(6):350-5. PubMed ID: 15597225
[TBL] [Abstract][Full Text] [Related]
5. [Borrelia strains that cause erythema migrans in Alsace, France].
Antoni-Bach N; Jaulhac B; Hansmann Y; Limbach F; Lipsker D
Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):15-8. PubMed ID: 11937923
[TBL] [Abstract][Full Text] [Related]
6. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in urine specimens of patients with erythema migrans lesions.
Mercier G; Burckel A; Lucotte G
Mol Cell Probes; 1997 Apr; 11(2):89-94. PubMed ID: 9160322
[TBL] [Abstract][Full Text] [Related]
7. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species.
Stanek G; Breier F; Menzinger G; Schaar B; Hafner M; Partsch H
Wien Klin Wochenschr; 1999 Dec; 111(22-23):951-6. PubMed ID: 10666807
[TBL] [Abstract][Full Text] [Related]
8. Borrelia burgdorferi stimulates macrophages to secrete higher levels of cytokines and chemokines than Borrelia afzelii or Borrelia garinii.
Strle K; Drouin EE; Shen S; El Khoury J; McHugh G; Ruzic-Sabljic E; Strle F; Steere AC
J Infect Dis; 2009 Dec; 200(12):1936-43. PubMed ID: 19909078
[TBL] [Abstract][Full Text] [Related]
9. Selective up-regulation of matrix metalloproteinase-9 expression in human erythema migrans skin lesions of acute lyme disease.
Zhao Z; Chang H; Trevino RP; Whren K; Bhawan J; Klempner MS
J Infect Dis; 2003 Oct; 188(8):1098-104. PubMed ID: 14551878
[TBL] [Abstract][Full Text] [Related]
10. [Skin manifestations of Lyme borreliosis in patients at the 1st Dermato-venereologic Clinic of Comenius University Medical School in Bratislava 1996-1998].
Svecová D; Buchvald J; Oprsalová K; Dolezalová A
Epidemiol Mikrobiol Imunol; 2000 Aug; 49(3):115-22. PubMed ID: 11040493
[TBL] [Abstract][Full Text] [Related]
11. [Concentration of macrophage inflammatory proteins MIP-1 alpha and MIP-1 beta and interleukin 8 in erythema migrants].
Grygorczuk SS; Pancewicz S; Kondrusik M; Zajkowska J; Swierzbińska R; Hermanowska-Szpakowicz T
Pol Merkur Lekarski; 2002 Jun; 12(72):458-61. PubMed ID: 12362660
[TBL] [Abstract][Full Text] [Related]
12. Has the presence or absence of Borrelia burgdorferi sensu lato as detected by skin culture any influence on the course of erythema migrans?
Logar M; Lotric-Furlan S; Maraspin V; Cimperman J; Jurca T; Ruzić-Sabljić E; Strle F
Wien Klin Wochenschr; 1999 Dec; 111(22-23):945-50. PubMed ID: 10666806
[TBL] [Abstract][Full Text] [Related]
13. Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early Lyme disease.
Wormser GP; Liveris D; Nowakowski J; Nadelman RB; Cavaliere LF; McKenna D; Holmgren D; Schwartz I
J Infect Dis; 1999 Sep; 180(3):720-5. PubMed ID: 10438360
[TBL] [Abstract][Full Text] [Related]
14. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
[TBL] [Abstract][Full Text] [Related]
15. Prospective clinical evaluation of patients from Missouri and New York with erythema migrans-like skin lesions.
Wormser GP; Masters E; Nowakowski J; McKenna D; Holmgren D; Ma K; Ihde L; Cavaliere LF; Nadelman RB
Clin Infect Dis; 2005 Oct; 41(7):958-65. PubMed ID: 16142659
[TBL] [Abstract][Full Text] [Related]
16. Antibody responses to borrelia IR(6) peptide variants and the C6 peptide in Swedish patients with erythema migrans.
Tjernberg I; Sillanpää H; Seppälä I; Eliasson I; Forsberg P; Lahdenne P
Int J Med Microbiol; 2009 Aug; 299(6):439-46. PubMed ID: 19138558
[TBL] [Abstract][Full Text] [Related]
17. Complement split products C3a and C4a are early markers of acute lyme disease in tick bite patients in the United States.
Shoemaker RC; Giclas PC; Crowder C; House D; Glovsky MM
Int Arch Allergy Immunol; 2008; 146(3):255-61. PubMed ID: 18270493
[TBL] [Abstract][Full Text] [Related]
18. Reduced number of interleukin-12 secreting cells in patients with Lyme borreliosis previously exposed to Anaplasma phagocytophilum.
Jarefors S; Karlsson M; Forsberg P; Eliasson I; Ernerudh J; Ekerfelt C
Clin Exp Immunol; 2006 Feb; 143(2):322-8. PubMed ID: 16412057
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous manifestations of Lyme borreliosis.
Berger BW
Rheum Dis Clin North Am; 1989 Nov; 15(4):627-34. PubMed ID: 2685922
[TBL] [Abstract][Full Text] [Related]
20. No detection of Borrelia burgdorferi-specific DNA in erythema migrans lesions after minocycline treatment.
Muellegger RR; Zoechling N; Soyer HP; Hoedl S; Wienecke R; Volkenandt M; Kerl H
Arch Dermatol; 1995 Jun; 131(6):678-82. PubMed ID: 7778919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
